Nektar Therapeutics (NKTR) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 10.86M | 21.81M | 11.79M | 11.18M | 10.46M | 29.18M | 24.12M | 23.49M | 21.64M | 23.89M | 24.14M | 20.5M |
| Revenue Growth % | 3.83% | -25.25% | -51.13% | -52.42% | -51.66% | 22.15% | -0.08% | 14.59% | 0.21% | 8.45% | 2.2% | -5.03% |
| Cost of Goods Sold | 151K | 0 | 196K | 0 | 0 | 7.98M | 4.43M | 9.74M | 8.53M | 7.28M | 12.43M | 6.99M |
| COGS % of Revenue | 1.39% | - | 1.66% | - | - | 27.34% | 18.38% | 41.47% | 39.44% | 30.49% | 51.49% | 34.12% |
| Gross Profit | 10.71M | 21.81M | 11.59M | 11.18M | 10.46M | 21.2M | 19.69M | 13.75M | 13.11M | 16.6M | 11.71M | 13.51M |
| Gross Margin % | 98.61% | 100% | 98.34% | 100% | 100% | 72.66% | 81.62% | 58.53% | 60.56% | 69.51% | 48.51% | 65.88% |
| Gross Profit Growth % | 2.39% | 2.87% | -41.11% | -18.72% | -20.18% | 27.68% | 68.1% | 1.81% | -9.83% | 5.14% | -37.21% | -18% |
| Operating Expenses | 48.97M | 40.9M | 43.13M | 47.41M | 54.99M | 6.85M | 54.03M | 63.52M | 48.53M | 50.11M | 56.58M | 64.1M |
| OpEx % of Revenue | 450.86% | 187.54% | 365.78% | 424.21% | 525.76% | 23.48% | 223.98% | 270.44% | 224.28% | 209.81% | 234.33% | 312.72% |
| Selling, General & Admin | 13.29M | 11.38M | 15.87M | 17.07M | 24.35M | 17.14M | 18.96M | 20.51M | 20.15M | 17.32M | 21.15M | 17.87M |
| SG&A % of Revenue | 122.35% | 52.19% | 134.64% | 152.77% | 232.75% | 58.73% | 78.58% | 87.32% | 93.11% | 72.51% | 87.59% | 87.17% |
| Research & Development | 35.68M | 29.71M | 27.25M | 29.89M | 30.48M | 28.75M | 35.03M | 29.72M | 27.41M | 29.94M | 24.07M | 29.68M |
| R&D % of Revenue | 328.51% | 136.25% | 231.14% | 267.44% | 291.4% | 98.53% | 145.21% | 126.54% | 126.66% | 125.36% | 99.69% | 144.79% |
| Other Operating Expenses | 0 | -196K | 0 | 447K | 169K | -1000K | 46K | 1000K | 975K | 1000K | 1000K | 1000K |
| Operating Income | -38.26M | -19.09M | -31.53M | -36.23M | -44.53M | 14.35M | -34.34M | -49.77M | -35.43M | -33.51M | -44.86M | -50.6M |
| Operating Margin % | -352.25% | -87.54% | -267.45% | -324.21% | -425.76% | 49.18% | -142.37% | -211.9% | -163.72% | -140.3% | -185.82% | -246.84% |
| Operating Income Growth % | 14.09% | -233.05% | 8.19% | 27.21% | -25.71% | 142.82% | 23.45% | 1.63% | 73.7% | 18.04% | -19.73% | -8.14% |
| EBITDA | -38.11M | -18.9M | -31.34M | -36.02M | -44.11M | 14.68M | -33.35M | -48.31M | -33.82M | -31.86M | -43.17M | -48.43M |
| EBITDA Margin % | -350.86% | -86.67% | -265.78% | -322.29% | -421.69% | 50.32% | -138.25% | -205.69% | -156.29% | -133.38% | -178.8% | -236.27% |
| EBITDA Growth % | 13.61% | -228.75% | 6.04% | 25.46% | -30.42% | 146.08% | 22.74% | 0.24% | 74.46% | 17.33% | -24.07% | -11.73% |
| D&A (Non-Cash Add-back) | 151K | 190K | 196K | 214K | 426K | 332K | 993K | 1.46M | 1.61M | 1.65M | 1.7M | 2.17M |
| EBIT | -38.26M | -19.09M | -29.51M | -34M | -41.4M | 17.16M | -31.03M | -45.91M | -31.31M | -35.24M | -39.99M | -45.02M |
| Net Interest Income | -3.7M | -6.99M | -3.23M | -3.42M | -2.1M | -7.21M | -2.58M | -2.51M | -1.31M | -1.92M | -1.03M | -1.31M |
| Interest Income | 4.24M | 2.78M | 2.82M | 1.97M | 2.87M | 2.94M | 3.44M | 3.9M | 4.22M | 4.95M | 4.88M | 4.85M |
| Interest Expense | 7.94M | 9.77M | 6.05M | 5.39M | 4.97M | 10.15M | 6.02M | 6.41M | 5.53M | 6.87M | 5.91M | 6.15M |
| Other Income/Expense | -6.58M | -16.96M | -4.02M | -5.55M | -6.29M | -7.35M | -2.7M | -2.54M | -1.41M | -8.6M | -1.03M | -570K |
| Pretax Income | -44.84M | -36.05M | -35.55M | -41.78M | -50.83M | 7M | -37.05M | -52.32M | -36.84M | -42.11M | -45.9M | -51.17M |
| Pretax Margin % | -412.85% | -165.3% | -301.57% | -373.88% | -485.95% | 24% | -153.57% | -222.73% | -170.23% | -176.29% | -190.1% | -249.62% |
| Income Tax | 64K | 31K | -33K | -188K | 52K | -259K | 9K | 46K | -35K | -29K | -61K | -47K |
| Effective Tax Rate % | -0.14% | -0.09% | 0.09% | 0.45% | -0.1% | -3.7% | -0.02% | -0.09% | 0.1% | 0.07% | 0.13% | 0.09% |
| Net Income | -44.9M | -36.08M | -35.52M | -41.59M | -50.88M | 7.26M | -37.06M | -52.36M | -36.8M | -42.08M | -45.84M | -51.12M |
| Net Margin % | -413.44% | -165.45% | -301.29% | -372.2% | -486.44% | 24.89% | -153.61% | -222.93% | -170.07% | -176.17% | -189.85% | -249.39% |
| Net Income Growth % | 11.75% | -596.89% | 4.14% | 20.57% | -38.26% | 117.26% | 19.15% | -2.43% | 73.14% | 29.5% | 22.37% | 67.86% |
| Net Income (Continuing) | -44.9M | -36.08M | -35.52M | -41.59M | -50.88M | 7.26M | -37.06M | -52.36M | -36.8M | -42.08M | -45.84M | -51.12M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.82 | -1.78 | -1.87 | -2.95 | -3.62 | 0.51 | -2.66 | -3.76 | -2.83 | -3.30 | -3.61 | -4.05 |
| EPS Growth % | 49.72% | -449.02% | 29.7% | 21.54% | -27.92% | 115.45% | 26.32% | 7.16% | 74.16% | 31.25% | 22.37% | 68.24% |
| EPS (Basic) | -1.82 | -1.78 | -1.87 | -2.95 | -3.62 | 0.52 | -2.66 | -3.76 | -2.83 | -3.30 | -3.61 | -4.05 |
| Diluted Shares Outstanding | 24.74M | 20.3M | 14.09M | 14.09M | 14.06M | 14.24M | 13.95M | 13.92M | 12.98M | 12.74M | 12.69M | 12.64M |
| Basic Shares Outstanding | 24.74M | 20.3M | 14.09M | 14.09M | 14.06M | 13.98M | 13.95M | 13.92M | 12.98M | 12.74M | 12.69M | 12.64M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |